APIM Therapeutics will be presenting an abstract entitled "Increased efficacy of intravesical chemotherapy in an orthotopic rat bladder cancer model by targeting PCNA with the novel synthetic peptide drug ATX-101" at the Annual Meeting of the American Association of Urology held in San Diego in May 4-8, 2013.
APIM Therapeutics will be presenting an abstract entitled "Targeting DNA repair mechanisms increases efficiency of intravesical chemotherapy in an orthotopic rat bladder cancer model" at the 28th Annual European Urology Association Meeting held in Milan in March 15-19, 2013.
APIM Therapeutics has been selected to present at the 6th ANNUAL EUROPEAN LIFE SCIENCE CEO FORUM PARTNERING & INVESTING in Biotech & Pharma Industry. The conference, which takes place in March 5-6, 2013 in Zurich, brings together together an exciting cross-section of venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders.
APIM Therapeutics has been selected to present at the 12th Biotech In Europe Investor Forum. The conference, which takes place in October 1-2, 2012 in Zurich, brings together venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders.
APIM Therapeutics will present a poster entitled "A novel APIM-motif comprising peptide drug potentiates the action of several chemotherapeutic drugs by blocking the interaction between PCNA and key proteins involved in DNA repair, apoptosis and cell cycle control" at the Annual Meeting of the American Cancer Association (AACR), taking place in Chicago, USA (March 31- April 4). The poster (#4676) will be presented on Tuesday, April 03, at the poster session 30, Hall F, 1:00 pm - 5:00 pm.
APIM Therapeutics has been selected to present at the 5th Annual European Life Science CEO Forum For Partnering & Investing. The conference, which takes place in March 6-7, 2012 in Zurich, will focus on executive-level networking, deal-making and partnering in the Life Science and Biotech Industries.
A panel of industry experts has selected APIM Therapeutics to present at BIO-Europe Spring 2012, the springtime counterpart to BIO-Europe. The conference, which takes place in March 19–21, 2012 in Amsterdam, focuses on biotechnology companies interested in partnering their technologies or products, initiating strategic alliances, or tapping into the international financing network.